Article metrics

Download PDFPDF
CP-022 Cost-efficacy model of the introduction of emtricitabine/rilpivirine/tenofovir vs. the combination of tenofovir/emtricitabine + generic efavirenz in Spanish clinical practice

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014400
Mar 2014600
Apr 2014200
Jun 2014601
Jul 2014801
Aug 2014200
Sep 2014200
Oct 2014200
Nov 2014500
Dec 2014500
Jan 20151201
Feb 2015500
Mar 2015102
Apr 2015500
May 2015700
Jun 2015200
Jul 2015100
Aug 20151300
Sep 20151100
Oct 20151200
Nov 20152201
Dec 2015900
Jan 20161000
Feb 2016600
Mar 2016600
Apr 2016802
May 20161200
Jun 20161200
Jul 20162101
Aug 20164200
Sep 20165500
Oct 20164900
Nov 20162501
Dec 20162300
Jan 20171900
Feb 2017700
Mar 20171300
Apr 20171000
May 20171700
Jun 2017500
Jul 20171200
Aug 20171200
Sep 20171600
Oct 20171600
Nov 20172000
Dec 20172600
Jan 20182600
Feb 20185400
Mar 20188600
Apr 20185801
May 20183000
Jun 20182200
Jul 20181800
Aug 20182800
Sep 20182000
Oct 20181600
Nov 20183200
Dec 20182800
Jan 20193200
Feb 20193600
Mar 20191801
Apr 2019600
Jun 2019600
Jul 2019600
Sep 2019600
Oct 2019200
Nov 20191000
Dec 2019400
Jan 20201200
Feb 2020400
May 2020200
Jun 2020800
Jul 20201000
Aug 20201201
Sep 20201000
Oct 2020600
Nov 20201600
Dec 2020600
Jan 2021501
Feb 20214602
Mar 20211800
Apr 2021200
Jul 2021200
Sep 2021100
Oct 2021400
Nov 20211501
Dec 2021900
Jan 20221700
Feb 20222600
Mar 20223500
Apr 20223400
May 20222600
Jun 20223800
Jul 20223100
Aug 20223800
Sep 2022400
Oct 2022700
Nov 20221800
Dec 20221100
Jan 2023600
Feb 2023400
Mar 20231000
Apr 2023200
May 2023200
Jun 2023200
Jul 2023200
Sep 2023400
Oct 2023200
Nov 2023400
Dec 2023600
Jan 20241000
Feb 2024600
Mar 2024800
Total1669017